Introduction: The aim of this study was to assess the effect of a community-based intervention on social capital, quality of life, self-care, and health literacy among elderly. Materials and Methods: This quasi-experimental trial was conducted at two health-care centers in Isfahan, Iran, which assigned to the intervention and control groups. A total of 86 elderly (60 years or above) enrolled in the study. The intervention program consisted of 12 weekly group sessions with various health topics. Nine sessions held in the health-care center and three local tours in different locations of the neighborhood. The control group received routine care of health centers. Social capital, quality of life, self-care, and health literacy were assessed at baseline and 1 month after the intervention in two groups. Results: Mental component of quality of life ( P = 0.026), self-care, and health literacy ( P < 0.001) showed a significant increase in the intervention group compared to the control group at 1 month after the intervention. The total score of social capital and the dimensions of local community participation, social agency, feelings of security and trust, interactions with neighbors, and interactions with family and friends improved in the intervention group ( P < 0.001). However, there was no significant difference in the dimensions of tolerance of diversity ( P = 0.241) and value of life ( P = 0.928). Conclusions: This community-based interventions with a variety of diverse and participatory components can be used as a strategy to promote the health of the elderly in primary health care.

Background: We aimed to evaluate the effect of COVID-19 vaccines in preventing infection, hospitalization, and mortality due to COVID-19 in Isfahan Province, Iran. Methods: Following a retrospective cohort design, data of all vaccinated individuals since the rollout of vaccination of the general population are analyzed, Mar 2020 to Aug 13, 2021. Moreover, the data of all non-vaccinated people were collected by the census method for this period. The two groups were compared concerning hospitalization and mortality using the Chi-square test. Kaplan-Meyer was also used to calculate the median interval between receiving a vaccine and outcome (hospitalization and death). Results: Overall, 583434 people have received a second dose of a vaccine from Mar 2020 to Aug 2021, which 74% (n=433403) was Sinopharm, 18.2% (n=106027) AstraZeneca, 3.6% (n=21216) Sputnik, and 3.9% (n=22,788) Barekat. In contrast, 2,551,140 people living in the Isfahan Province did not receive a vaccine. The median interval between injection of the first dose and the hospitalization for those who received Sinopharm, AstraZeneca, Sputnik, and Barekat was 22, 61, 19, and 19 days, respectively. For unvaccinated cases, the rates of infection, hospitalization, and mortality (per 1000 population) were 69.7, 12.1, and 1.04, respectively. In contrast, for vaccinated individuals, these rates were 3.9, 1.08, and 0.09, two weeks after the second dose, respectively. Conclusion: The highest and lowest reduction in relative risk was for those who received AstraZeneca and Sputnik, respectively.

The article's abstract is not available.

Background and Aim: This study investigated the results of the non-communicable diseases prevention and control program in Isfahan under the supervision of the Vice Chancellor for Health of the University of Medical Sciences from 2017 to March 2021. Materials and Methods:In this cross-sectional study, the target group was all the population over 30 years in Isfahan province referring to health centers for screening programs for noncommunicable diseases and risk factors (cardiovascular and diabetes). Breast cancer screening was performed in women between 30 to 70 years and colorectal cancer screening was performed in men and women between 50 to 70 years. Results:The number of people diagnosed with diabetes at the end of March 2021 was 148,250 and its prevalence was 11.59%. Also, the number of patients with high blood pressure registered in electronic patient record from 2017 to the end of March 2021 was 249294 (prevalence 19.74%). In colorectal cancer screening, 1593 cases of polyps were detected from 5367 colonoscopies during 4 years of the program. Also, by screening 46.9% of the target population, 513 cases of breast cancer were detected. Conclusion:In the evaluation of the process of diagnosis and patient care, an increase was evident during 2017 to 2019, but there was a decrease in the number of risk assessments and patient care in 2020-2021 due to the COVID19 pandemic.